Recombinant lubricin (Lubris/Dompe/Novartis)

N/A

Report date: 2026/05/13 20:02:10

Base Information

Drug NameRecombinant lubricin (Lubris/Dompe/Novartis)
Drug Alias Namerh-lubricinlubricin recombinantRecombinant Human Proteoglycan 4ECF-843rhPRG-4
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionProteoglycan 4 replacements
TargetsProteoglycan 4
Therapy Area/IndicationsGraft vs Host DiseaseSjogren-Larsson SyndromeXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLubris Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesLubris Bio Pty Ltd
Active IndicationsGraft vs Host DiseaseSjogren-Larsson Syndrome
Inactive IndicationsXerophthalmia

Other Information

ATC CodeN/A
Related LinksN/A